News #Eli Lilly

Eli Lilly will acquire psychedelic drugmaker AtaiBeckley for $2.8 billion up front, the company said Thursday, as momentum grows for using versions of the drugs

Generative-AI drug developer Insilico Medicine said on Sunday that it has agreed a global licensing and research deal with US drugmaker Eli Lilly, that could be worth up to US$2.75 billion